Skip to main content
. 2019 Aug 7;17(8):461. doi: 10.3390/md17080461

Table 3.

Cytotoxicity (IC50 μg/mL) of compounds 1 to 7.

Compound Cell Lines IC50 (μg/mL)
A549 a DLD-1 b P388D1 c
1 9.7 ± 1.2 6.0 ± 0.4 7.2 ± 1.8
2 28.6 ± 3.8 31.6 ± 3.7 30.4 ± 4.8
3 d 19.6 ± 8.3
4
5
6
7 10.8 ± 4.9 11.7 ± 4.8 8.9 ± 2.2
Doxorubicin e 0.3 ± 0.1 1.5 ± 0.2 0.9 ± 0.2

a A549: Human lung adenocarcinoma. b DLD-1: Human colorectal adenocarcinoma. c P388D1: Mouse lymphocytic leukemia cell line. d IC50 > 40 μg/mL. e Clinical anticancer drug used as a positive control.